Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
97.80
-0.44 (-0.45%)
At close: Jul 3, 2025, 1:00 PM
98.50
+0.70 (0.72%)
After-hours: Jul 3, 2025, 4:27 PM EDT
Insmed Employees
Insmed had 1,271 employees as of December 31, 2024. The number of employees increased by 359 or 39.36% compared to the previous year.
Employees
1,271
Change (1Y)
359
Growth (1Y)
39.36%
Revenue / Employee
$299,788
Profits / Employee
-$797,218
Market Cap
18.58B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INSM News
- 17 days ago - Is Insmed Stock Overvalued After The 45% Jump? - Forbes
- 21 days ago - Insmed Announces Pricing of $750 Million Public Offering of Common Stock - PRNewsWire
- 22 days ago - Insmed Announces Proposed $650 Million Public Offering of Common Stock - PRNewsWire
- 22 days ago - Insmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price Forecast - Benzinga
- 23 days ago - Insmed: Company Presses On With Further POC PAH Treatment Data - Seeking Alpha
- 23 days ago - Insmed's blood pressure drug meets main goal in mid-stage trial - Reuters
- 23 days ago - Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension - PRNewsWire
- 4 weeks ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire